In a landmark ruling, the U.S. Supreme Court ensures that health insurers must continue to cover preventive services like cancer screenings and HIV medications at no cost to patients. This decision safeguards vital health benefits amidst ongoing challenges to Obamacare.
In a landmark decision, the Supreme Court confirmed the constitutionality of the US Preventive Services Task Force, protecting no-cost health care services for 150 million Americans. This ruling comes as a relief to public health advocates amid challenges from Christian-owned businesses.
In a controversial ruling, the Supreme Court allows South Carolina to block Planned Parenthood from receiving federal Medicaid funds for non-abortion services, raising concerns over healthcare access and patients' rights.
Colorectal cancer screening is evolving with the fecal immunochemical test (FIT), a non-invasive alternative to colonoscopy. Discover how FIT works and its benefits for younger adults seeking early detection.
Former President Biden's prostate cancer diagnosis has reignited the debate over the effectiveness of PSA testing, a screening tool fraught with risks and benefits. Experts weigh in on the complexities of detecting aggressive cancers versus over-treatment of indolent cases.
In a stunning revelation, former President Joe Biden's office confirmed his prostate cancer diagnosis, raising questions about the timing and implications for his 2024 campaign. Experts weigh in on the risks and treatment options.
The FDA has approved the first at-home cervical cancer screening test, the Teal Wand, developed by Teal Health. This less invasive option aims to make screenings more accessible and comfortable for women, potentially eradicating cervical cancer in our lifetime.
The FDA has approved the Teal Wand, the first at-home alternative to Pap smears, offering a painless and convenient way for women to screen for cervical cancer. With the aim of increasing screening rates, this innovative device allows women to collect samples at home and mail them for lab testing.
The FDA has approved an innovative at-home cervical cancer screening tool, allowing women to self-collect samples and mail them for HPV testing, making screenings more accessible and comfortable.
A groundbreaking urine test for prostate cancer has shown remarkable accuracy, outperforming traditional blood tests. Set to enter clinical trials, this innovation may make routine screenings a reality, potentially saving thousands of lives.
